Rhumbline Advisers Dario Health Corp. Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$4.33 - $7.45 $66,569 - $114,536	-15,374 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$5.84 - $13.61 $3,095 - $7,213	530 Added 3.57%	15,374 $90,000
Q4 2021 Feb 10, 2022	SELL	$12.52 - $19.02 $5,834 - $8,863	-466 Reduced 3.04%	14,844 $193,000
Q3 2021 Nov 12, 2021	BUY	$10.47 - $20.87 $6,543 - $13,043	625 Added 4.26%	15,310 $209,000
Q2 2021 Aug 05, 2021	BUY	$13.9 - $22.58 $204,121 - $331,587	14,685 New	14,685 $314,000

7.99M

104K

5.6K

Ticker DRIO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 23,295,000
Market Cap $17.2M
Description
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.